I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Ten-year results of intense dose-dense chemotherapy show su..:
Möbus, V
;
Jackisch, C
;
Lück, HJ
...
qt5h53w3r1. , 2018
Link:
https://escholarship.org/uc/item/5h53w3r1
RT Journal T1
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt5h53w3r1&Exemplar=1&LAN=DE A1 Möbus, V A1 Jackisch, C A1 Lück, HJ A1 du Bois, A A1 Thomssen, C A1 Kuhn, W A1 Nitz, U A1 Schneeweiss, A A1 Huober, J A1 Harbeck, N A1 von Minckwitz, G A1 Runnebaum, IB A1 Hinke, A A1 Konecny, GE A1 Untch, M A1 Kurbacher, C A1 Group, AGO Breast Study PB eScholarship, University of California YR 2018 K1 Biomedical and Clinical Sciences K1 Oncology and Carcinogenesis K1 Clinical Research K1 Cancer K1 Clinical Trials and Supportive Activities K1 Breast Cancer K1 Evaluation of treatments and therapeutic interventions K1 6.1 Pharmaceuticals K1 Adult K1 Aged K1 Antineoplastic Combined Chemotherapy Protocols K1 Breast Neoplasms K1 Cyclophosphamide K1 Disease-Free Survival K1 Dose-Response Relationship K1 Drug K1 Epirubicin K1 Female K1 Humans K1 Lymphatic Metastasis K1 Middle Aged K1 Paclitaxel K1 Risk Factors K1 Survival Rate K1 high-risk early breast cancer K1 dose-dense K1 intense dose-dense K1 AGO Breast Study Group K1 Oncology & Carcinogenesis K1 Clinical sciences JF qt5h53w3r1 LK http://dx.doi.org/https://escholarship.org/uc/item/5h53w3r1 DO https://escholarship.org/uc/item/5h53w3r1 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)